(Total Views: 384)
Posted On: 05/05/2020 9:23:22 AM
Post# of 208

$TSOI Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune™
Company Intends to Initiate Clinical Trials using Novel "Multipronged" Attack on Coronavirus Pathology
https://www.prnewswire.com/news-releases/ther...52960.html
Company Intends to Initiate Clinical Trials using Novel "Multipronged" Attack on Coronavirus Pathology
https://www.prnewswire.com/news-releases/ther...52960.html

